Categories: Wire Stories

2024 Mitsui Chemicals Catalysis Science Awards

Online applications open September 2023

TOKYO–(BUSINESS WIRE)–Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) today announced that online applications for the 2024 Mitsui Chemicals Catalysis Science Awards will open on September 1, 2023.


Aiming to contribute to the sustainable development of chemistry and the chemical industry, Mitsui Chemicals established the Mitsui Chemicals Catalysis Science Awards in 2004. The awards consist of the Catalysis Science Award and the Catalysis Science Award for Creative Work, which recognize outstanding achievements in the field of catalysis science. To date, the awards have been conferred on 30 researchers within Japan and overseas. The application requirements for the 2024 Mitsui Chemicals Catalysis Science Awards are outlined below.

We welcome applications from a wide range of R&D fields, including solid catalysts, molecular catalysts and biocatalysts, as well as green processes and rare metal utilization via catalysis, along with materials science and development through novel catalysis.

The Mitsui Chemicals Catalysis Science Awards:

https://jp.mitsuichemicals.com/en/techno/csa/index.htm

I. Outline of awards

 

Mitsui Chemicals Catalysis Science Award

Mitsui Chemicals Catalysis Science Award for Creative Work

Eligible applicants

Researchers affiliated to a university or public research institution, who have demonstrated extraordinary achievements in the field of catalysis science research (prize may be awarded to up to one winner)

Researchers affiliated to a university or public research institution, who have demonstrated creative achievements in the field of catalysis science research (prize may be awarded to up to two winners)

Application requirements

Applicants must be no more than 47 years old as of April 1, 2023

Applicants must be no more than 37 years old as of April 1, 2023

Prize

A plaque and prize money of 5 million yen

A plaque and prize money of 1 million yen

II. Schedule and selection process

Applications open

September 1, 2023

Applications close

December 31, 2023

Selection process

Winners will be chosen by a selection committee organized by Mitsui Chemicals, consisting of several eminent academics in the field of catalysis science and a Mitsui Chemicals representative.

Announcement of winners

In June 2024 or thereabouts (details will be published on the website and in professional journals, among other sources)

Please review the information at the link above for further details of the application process, including the application documents and information to be submitted, important notes concerning applications and information on the handling of personal information.

Contacts

Contacts for inquiries

Corporate Communication Div.

Mitsui Chemicals, Inc.

URL: https://form.mitsuichemicals.com/corporate/cc_pr_csr_en

Alex

Recent Posts

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

− Takeda to receive exclusive option to license global rights to ACI-24.060, a potential first-in-class…

1 min ago

Shine Bright at Juicy Stakes Casino With Some Dazzling Bonus Action

SYDNEY--(BUSINESS WIRE)--Want to shine bright like a diamond? Then Juicy Stakes Casino is the place…

3 mins ago

FPT Software and Forthcode Join Forces to Revolutionize Inflight Operations

HANOI, Vietnam--(BUSINESS WIRE)--#DigitalTransformation--Global technology company FPT Software recently announced a strategic partnership with Forthcode, an…

1 hour ago

Cleanbed Offers Free Home Cleaning Sessions

SINGAPORE - Media OutReach Newswire - 13 May 2024 - Cleanbed, a mattress cleaning company…

1 hour ago

UXLINK Secures New Round of Funding from SevenX Ventures, INCE Capital , and HashKey Capital

SINGAPORE - Media OutReach Newswire - 13 May 2024 - UXLINK, the leading Web3 social…

3 hours ago

Avata Biosciences Emerges to Develop Solid Dose Cannabinoid Medicines for Epilepsy and Other Neurological Diseases

Lead Candidate SAP-021 to be Developed on 505(b)(2) FDA Regulatory Pathway Based on Phase 1…

3 hours ago